Oppenheimer Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.37M Buy
2,608
+643
+33% +$338K 0.02% 680
2025
Q1
$1.25M Buy
+1,965
New +$1.25M 0.02% 668
2023
Q4
Sell
-756
Closed -$622K 1177
2023
Q3
$622K Buy
756
+22
+3% +$18.1K 0.01% 795
2023
Q2
$527K Buy
734
+15
+2% +$10.8K 0.01% 850
2023
Q1
$591K Sell
719
-62
-8% -$50.9K 0.01% 806
2022
Q4
$563K Sell
781
-216
-22% -$156K 0.01% 821
2022
Q3
$687K Sell
997
-59
-6% -$40.7K 0.01% 758
2022
Q2
$624K Buy
1,056
+98
+10% +$57.9K 0.01% 797
2022
Q1
$669K Sell
958
-1,841
-66% -$1.29M 0.01% 850
2021
Q4
$1.77M Sell
2,799
-88
-3% -$55.6K 0.02% 592
2021
Q3
$1.75M Buy
2,887
+318
+12% +$192K 0.02% 578
2021
Q2
$1.44M Buy
2,569
+222
+9% +$124K 0.02% 638
2021
Q1
$1.11M Sell
2,347
-23,363
-91% -$11.1M 0.02% 690
2020
Q4
$12.4M Buy
25,710
+997
+4% +$482K 0.21% 121
2020
Q3
$13.8M Buy
24,713
+136
+0.6% +$76.1K 0.27% 92
2020
Q2
$15.3M Buy
24,577
+1,357
+6% +$846K 0.32% 75
2020
Q1
$11.3M Buy
23,220
+22,739
+4,727% +$11.1M 0.28% 85
2019
Q4
$181K Sell
481
-30
-6% -$11.3K ﹤0.01% 1081
2019
Q3
$142K Sell
511
-5
-1% -$1.39K ﹤0.01% 1114
2019
Q2
$162K Sell
516
-49
-9% -$15.4K ﹤0.01% 1098
2019
Q1
$233K Sell
565
-806
-59% -$332K 0.01% 995
2018
Q4
$512K Sell
1,371
-60
-4% -$22.4K 0.01% 755
2018
Q3
$578K Buy
1,431
+128
+10% +$51.7K 0.01% 772
2018
Q2
$449K Buy
1,303
+218
+20% +$75.1K 0.01% 826
2018
Q1
$374K Sell
1,085
-9,524
-90% -$3.28M 0.01% 862
2017
Q4
$4.75M Hold
10,609
0.13% 184
2017
Q3
$4.75M Buy
10,609
+258
+2% +$115K 0.12% 186
2017
Q2
$5.08M Buy
10,351
+340
+3% +$167K 0.14% 173
2017
Q1
$3.88M Buy
+10,011
New +$3.88M 0.11% 216